Literature DB >> 3215193

Right ventricular performance and pulmonary haemodynamics in adolescent and adult patients with cystic fibrosis.

O C Burghuber1, U Salzer-Muhar, H Bergmann, M Götz.   

Abstract

A combined haemodynamic and radionuclide approach was used to evaluate right ventricular performance in 16 adolescent and adult patients with cystic fibrosis (CF). There were nine patients with mild arterial hypoxaemia (PaO2 greater than 80% of predicted) and normal resting pulmonary artery pressure and seven patients with severe arterial hypoxaemia (PaO2 less than 70% of predicted) and resting pulmonary arterial hypertension (PH). The right ventricular ejection fraction (RVEF) by equilibrium angiocardiography using krypton 81m as a tracer and stroke volume index (SVI) by thermodilution techniques were measured simultaneously and right ventricular end-diastolic and end-systolic volumes were derived. RVEF was normal in CF patients without PH (58.9 +/- 7.2%) but was reduced in those with PH (45.4 +/- 2.6%). There was a statistically significant inverse linear correlation between RVEF and afterload as assessed by mean pulmonary artery pressure (Pap: r = -0.76) and pulmonary vascular resistance (PVR: r = -0.78), indicating that RVEF ist afterload-dependent. Right ventricular function, however, as assessed by right ventricular end-systolic pressure-volume relations was even higher in CF patients with PH, indicating preserved or even increased right ventricular function in the face of an increased afterload stress.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3215193     DOI: 10.1007/bf00441398

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  26 in total

1.  Cor pulmonale in infancy and early childhood; report on 34 patients, with special reference to the occurrence of pulmonary heart disease in cystic fibrosis of the pancreas.

Authors:  S W ROYCE
Journal:  Pediatrics       Date:  1951-08       Impact factor: 7.124

2.  Noninvasive evaluation of ventricular function in cystic fibrosis.

Authors:  B E Chipps; P O Alderson; J M Roland; S Yang; A van Aswegen; C R Martinez; B J Rosenstein
Journal:  J Pediatr       Date:  1979-09       Impact factor: 4.406

3.  Instantaneous pressure-volume relationships and their ratio in the excised, supported canine left ventricle.

Authors:  H Suga; K Sagawa
Journal:  Circ Res       Date:  1974-07       Impact factor: 17.367

4.  Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio.

Authors:  H Suga; K Sagawa; A A Shoukas
Journal:  Circ Res       Date:  1973-03       Impact factor: 17.367

5.  Radionuclide assessment of cardiac performance in cystic fibrosis. Reproducibility and effect of theophylline on cardiac function.

Authors:  G J Canny; M E de Souza; D L Gilday; C J Newth
Journal:  Am Rev Respir Dis       Date:  1984-11

6.  Hemodynamic correlates of right ventricular ejection fraction measured with gated radionuclide angiography.

Authors:  K S Korr; E J Gandsman; M L Winkler; R S Shulman; E W Bough
Journal:  Am J Cardiol       Date:  1982-01       Impact factor: 2.778

7.  Right ventricular performance in chronic air flow obstruction.

Authors:  O Burghuber; H Bergmann; K Silberbauer; R Höfer
Journal:  Respiration       Date:  1984       Impact factor: 3.580

Review 8.  The cardiovascular system in cystic fibrosis.

Authors:  A J Moss
Journal:  Pediatrics       Date:  1982-11       Impact factor: 7.124

9.  Right ventricular ejection fraction measured by first-pass intravenous krypton-81m: reproducibility and comparison with technetium-99m.

Authors:  D F Wong; T K Natarajan; W Summer; P A Tibbits; T Beck; D Koller; W Kasecamp; J Lamb; J Olynyk; M S Philp
Journal:  Am J Cardiol       Date:  1985-11-01       Impact factor: 2.778

10.  Nifedipine attenuates acute hypoxic pulmonary vasoconstriction in patients with chronic obstructive pulmonary disease.

Authors:  O C Burghuber
Journal:  Respiration       Date:  1987       Impact factor: 3.580

View more
  3 in total

Review 1.  The heart in cystic fibrosis.

Authors:  Rowland J Bright-Thomas; A Kevin Webb
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 2.  Pulmonary hypertension survival effects and treatment options in cystic fibrosis.

Authors:  Adriano R Tonelli
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

3.  Raised circulating plasma levels of atrial natriuretic peptide in adolescent and adult patients with cystic fibrosis and pulmonary artery hypertension.

Authors:  O C Burghuber; E Hartter; M Weissel; W Wolosczcuk; M Götz
Journal:  Lung       Date:  1991       Impact factor: 2.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.